RadOnc and Recon: Surveying the Landscape of Radiation and Reconstruction in Breast Cancer
摘要
Breast cancer is highly prevalent, impacting more women every year. Treatment may include surgery, radiation, and/or medication based on patients’ pathology and preferences. Nuances of treatment are difficult to discern with rapidly advancing therapies but warrant further clarity to ease patient-decision making. The aim of this review is to explore current reconstruction and radiation options and indications to better inform patient-provider teams.
Recent FindingsReconstruction and radiation in particular are complex fields with some overlap. Reconstruction offers two primary options: autologous and implant-based, which have variable risk profiles and patient satisfaction. Post-mastectomy radiation is indicated for high-risk patients and can be given under standard fractionation or hypofractionation, which safely offers equivalent total dosing in reduced sessions.
SummaryReconstruction with or without radiotherapy present complex paths forward especially with variable evidence. Optimal communication with patients requires discussion regarding evidence-based outcomes, patients’ goals, and expectation setting. Further research is required to better understand patient outcomes.